Complete Filing Data
TG THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $79.15 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TG THERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $447.2M | $23.4M | $12.7M | -$223.8M | -$348.1M | -$279.4M | -$172.9M | -$173.5M | -$118.5M | -$78.3M | -$62.9M | -$55.8M | -$20.5M | -$18.1M | -$853.1K |
| Cost of Revenue * | $100.7M | $38.5M | $14.1M | $265.0K | $790.0K | ||||||||||
| Revenue * | $616.3M | $329.0M | $233.7M | $2.8M | $6.7M | $152.0K | $152.0K | $152.0K | $152.0K | $152.0K | |||||
| Research And Development Expense | $160.2M | $94.3M | $76.2M | $125.4M | $222.6M | $165.9M | $154.2M | $159.4M | $102.5M | $69.2M | $47.7M | $40.1M | $13.7M | $21.0M | $327.3K |
| Operating Income Loss | $123.3M | $41.9M | $20.6M | -$218.3M | -$344.8M | -$273.6M | -$169.1M | -$174.4M | -$118.7M | -$79.0M | -$63.2M | -$55.7M | -$23.0M | -$26.9M | -$882.0K |
| Operating Expenses | $195.6M | $351.5M | $273.7M | $169.2M | $174.6M | $118.9M | $79.1M | $63.3M | $55.9M | $23.1M | $26.9M | $882.0K | |||
| Nonoperating Income Expense | -$15.9M | -$16.3M | -$7.6M | -$5.5M | -$3.3M | -$5.8M | -$3.8M | $918.0K | $236.0K | $716.0K | $231.4K | -$60.2K | $2.5M | $1.0M | -$7.1K |
| Non Cash Compensation Research And Development Expenses | $16.6M | $11.2M | $13.0M | $13.2M | $24.0M | $14.0M | $5.8M | $5.6M | $5.6M | $2.7M | $4.3M | $8.7M | $1.0M | $455.8K | $0.00 |
| Other Research And Development Expense | $143.6M | $83.1M | $63.2M | $112.1M | $198.5M | $151.9M | $148.3M | $149.8M | $96.9M | $66.5M | $43.4M | $26.0M | $12.6M | $4.0M | |
| Interest Expense | $12.6M | $10.2M | $5.6M | $6.3M | $5.3M | $877.0K | $845.0K | $972.7K | $930.7K | $952.9K | $905.7K | $7.1K | |||
| General And Administrative Expense | $107.9M | $15.0M | $15.2M | $16.3M | $9.9M | $15.6M | $15.8M | $6.7M | $4.8M | $554.7K | |||||
| Other General And Administrative Expense | $41.5M | $9.5M | $7.9M | $6.0M | $5.1M | $4.2M | $3.4M | $2.5M | $1.8M | $468.2K | |||||
| Non Cash Compensation General And Administrative Expenses | $66.3M | $5.5M | $7.3M | $10.3M | $4.8M | $11.4M | $12.4M | $4.2M | $3.0M | $86.5K | |||||
| Prepaid Research And Development | $4.2M | $4.2M | $11.9M | $5.2M | $8.1M | $9.7M | $8.1M | $5.7M | $9.2M | $6.2M | $1.7M | $2.0M | |||
| Licenses Revenue | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $19.0K | $0.00 | ||||||||
| Deferred Revenue Current | $21.2M | $11.4M | $152.0K | $152.0K | $152.0K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $0.00 | ||||
| Selling General And Administrative Expense | $232.0M | $154.3M | $122.7M | $95.5M | $128.1M | $107.9M | $15.0M | ||||||||
| Other Selling General And Administrative Expense | $184.0M | $122.9M | $97.8M | $64.0M | $90.9M | $41.5M | $9.5M | ||||||||
| Non Cash Compensation Selling General And Administrative Expenses | $48.1M | $31.4M | $24.9M | $31.4M | $37.2M | $66.3M | $5.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $390.9M | $28.2M | $5.1M | $3.9M | $6.9M | -$10.7M | $113.9M | -$47.6M | -$39.2M | -$35.8M | -$40.5M | -$69.0M | -$85.6M | -$78.5M | -$90.6M | -$87.2M | -$52.9M | -$51.1M | -$61.9M | -$36.2M | -$35.2M | -$34.0M | -$44.1M | -$41.5M | -$31.5M | -$28.4M | -$27.7M | -$24.8M | -$15.9M | -$13.8M | -$13.7M | -$17.1M | -$14.6M | -$17.5M | -$12.0M | -$7.5M | -$4.6M | -$6.6M | -$3.7M | -$2.5M | -$1.9M | -$10.3M | -$28.6K | $41.2K | ||||||||
| Cost of Revenue * | $28.1M | $18.9M | $15.5M | $9.3M | $8.3M | $5.4M | $3.5M | $1.9M | $857.0K | $2.0K | $139.0K | |||||||||||||||||||||||||||||||||||||||||
| Revenue * | $161.7M | $141.1M | $120.9M | $83.9M | $73.5M | $63.5M | $165.8M | $16.1M | $7.8M | $94.0K | $594.0K | $2.0M | $2.0M | $1.5M | $793.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | ||||||||||||||||||||||||||
| Research And Development Expense | $40.9M | $31.8M | $46.4M | $20.1M | $17.6M | $32.7M | $14.8M | $28.1M | $15.9M | $20.8M | $26.9M | $48.0M | $52.0M | $44.9M | $63.1M | $50.5M | $36.4M | $36.0M | $58.0M | $32.9M | $32.4M | $33.4M | $38.7M | $35.0M | $27.1M | $26.7M | $22.7M | $21.8M | $13.5M | $11.6M | $11.6M | $11.3M | $9.6M | $13.7M | $6.8M | $4.4M | $3.3M | $5.0M | $1.6M | $1.6M | $1.6M | $16.7M | $15.9K | $236.7K | ||||||||
| Operating Income Loss | $29.4M | $34.8M | $8.6M | $12.4M | $8.8M | -$9.3M | $114.8M | -$44.7M | -$37.0M | -$35.0M | -$38.9M | -$66.9M | -$85.1M | -$77.5M | -$89.2M | -$85.7M | -$50.8M | -$50.2M | -$60.9M | -$35.5M | -$34.7M | -$34.3M | $44.3M | -$41.6M | -$31.6M | -$28.4M | -$27.7M | -$24.9M | -$16.0M | -$14.0M | -$13.8M | -$17.1M | -$14.6M | -$17.4M | -$12.0M | -$7.6M | -$4.6M | -$6.6M | -$3.7M | -$2.7M | -$3.1M | -$17.4M | -$30.1K | -$515.6K | ||||||||
| Operating Expenses | $60.7M | $44.8M | $35.1M | $39.5M | $68.9M | $87.2M | $79.0M | $90.0M | $85.8M | $50.9M | $50.3M | $38.0M | $60.9M | $35.6M | $34.7M | $54.2M | $34.4M | $44.4M | $41.6M | $31.1M | $31.6M | $28.5M | $27.7M | $24.1M | $25.0M | $16.1M | $14.0M | $17.7M | $13.9M | $17.1M | $14.6M | $18.8M | $17.5M | $12.0M | $7.6M | $4.7M | $6.7M | $3.8M | $2.7M | $3.1M | $17.4M | $30.1K | ||||||||||
| Nonoperating Income Expense | -$3.5M | -$3.9M | -$3.2M | -$8.2M | -$2.3M | -$1.4M | -$854.0K | -$2.9M | -$2.2M | -$855.0K | -$1.6M | -$2.1M | -$509.0K | -$1.0M | -$1.4M | -$1.4M | -$2.0M | -$871.0K | -$1.1M | -$669.0K | -$467.0K | -$377.0K | $203.0K | $48.0K | $49.0K | $72.0K | -$61.0K | $94.4K | $124.4K | $143.5K | $169.7K | $8.4K | $25.1K | -$11.8K | -$30.9K | $57.9K | $91.2K | $44.2K | $40.4K | $4.0K | $530.8K | $11.2K | $0.00 | |||||||||
| Non Cash Compensation Research And Development Expenses | $5.3M | $4.3M | $3.3M | $3.0M | $2.5M | $2.5M | $2.9M | $5.7M | $1.6M | $3.2M | $2.3M | $1.9M | $4.5M | $7.0M | $7.5M | $4.6M | $1.6M | $2.0M | $1.5M | $1.4M | $1.5M | $0.00 | $3.0M | $2.9M | $0.00 | $0.00 | $2.3M | $919.6K | $567.2K | $386.9K | $35.8K | $1.4M | $1.3M | $1.2M | $3.3M | $1.9M | $171.4K | $366.2K | $354.7K | $127.1K | $109.2K | $0.00 | ||||||||||
| Other Research And Development Expense | $35.5M | $27.5M | $43.0M | $17.1M | $15.0M | $30.3M | $11.8M | $22.5M | $14.3M | $17.6M | $24.5M | $46.1M | $47.4M | $37.9M | $55.6M | $45.8M | $34.9M | $34.0M | $56.5M | $31.4M | $30.9M | $32.8M | $34.8M | $34.8M | $25.3M | $25.4M | $20.4M | $20.9M | $13.0M | $11.2M | $11.5M | $9.9M | $8.3M | $8.4M | $2.3M | $2.5M | $3.1M | $4.7M | $1.2M | |||||||||||||
| Interest Expense | $2.3M | $3.7M | $3.6M | $2.8M | $1.6M | $3.0M | $2.7M | $1.0M | $1.6M | $1.9M | $1.6M | $2.2M | $1.2M | $1.5M | $1.1M | $774.0K | $221.0K | $211.5K | $220.8K | $242.4K | $246.5K | $246.5K | $237.7K | $234.8K | $234.8K | $226.3K | $240.5K | $240.0K | $231.5K | $228.6K | $228.1K | -$220.1K | $0.00 | -$349.6K | ||||||||||||||||||
| General And Administrative Expense | $35.3M | $14.4M | $14.3M | $2.9M | $2.7M | $2.3M | $968.0K | $5.7M | $6.6M | $4.5M | $1.8M | $5.0M | $3.2M | $2.5M | $2.4M | $2.3M | $5.9M | $5.0M | $3.8M | $5.1M | $3.2M | $1.4M | $1.6M | $2.2M | $1.2M | $1.5M | $644.0K | $14.2K | $278.9K | |||||||||||||||||||||||
| Other General And Administrative Expense | $11.6M | $8.6M | $5.2M | $2.3M | $2.3M | $1.9M | $1.8M | $2.3M | $2.1M | $1.4M | $1.5M | $1.3M | $1.3M | $1.4M | $1.1M | $1.1M | $1.0M | $1.0M | $889.9K | $706.7K | $903.5K | $550.6K | $631.6K | $651.5K | $462.4K | $396.0K | $455.5K | $14.2K | ||||||||||||||||||||||||
| Non Cash Compensation General And Administrative Expenses | $23.7M | $5.8M | $9.1M | $593.0K | $405.0K | $393.0K | -$817.0K | $3.4M | $4.5M | $3.1M | $223.0K | $3.7M | $1.9M | $1.1M | $1.3M | $1.2M | $4.9M | $4.0M | $2.9M | $4.4M | $2.3M | $825.3K | $1.0M | $1.5M | $691.0K | $1.1M | $0.00 | |||||||||||||||||||||||||
| Prepaid Research And Development | $5.0M | $4.9M | $4.8M | $4.0M | $3.6M | $4.1M | $11.0M | $7.7M | $5.6M | $5.5M | $3.8M | $7.7M | $7.0M | $8.5M | $11.1M | $11.4M | $8.9M | $6.8M | $5.0M | $9.7M | $8.4M | $10.1M | $14.5M | $11.0M | $10.0M | $10.9M | $9.8M | $9.1M | $4.0M | $2.4M | $311.5K | $615.3K | $1.7M | $0.00 | ||||||||||||||||||
| Licenses Revenue | $38.0K | $38.1K | $38.1K | $38.0K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $38.1K | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||
| Deferred Revenue Current | $26.4M | $23.9M | $17.1M | $9.1M | $3.4M | $3.4M | $6.9M | $152.0K | $152.0K | $152.0K | $152.0K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | $152.4K | |||||||||||||||||||||||||||
| Selling General And Administrative Expense | $63.4M | $55.6M | $50.3M | $42.0M | $38.8M | $34.6M | $32.8M | $30.7M | $28.1M | $14.3M | $12.6M | $20.6M | $34.9M | $34.0M | $26.8M | $35.3M | $14.4M | $14.3M | ||||||||||||||||||||||||||||||||||
| Other Selling General And Administrative Expense | $51.0M | $43.5M | $38.7M | $33.2M | $31.8M | $27.7M | $26.5M | $23.8M | $22.8M | $10.5M | $15.9M | $20.4M | $25.4M | $24.7M | $17.7M | $11.6M | $8.6M | $5.2M | ||||||||||||||||||||||||||||||||||
| Non Cash Compensation Selling General And Administrative Expenses | $12.4M | $12.0M | $11.6M | $8.7M | $7.0M | $6.9M | $6.3M | $6.9M | $5.2M | $3.7M | -$3.3M | $226.0K | $9.5M | $9.3M | $9.1M | $23.7M | $5.8M | $9.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $648.0M | $222.4M | $160.5M | $58.6M | $237.2M | $519.4M | $38.6M | $24.0M | $67.0M | $35.9M | $101.6M | $80.1M | $40.1M | $15.6M | $9.6M | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $79.1M | $179.9M | $92.9M | $102.3M | $298.9M | $553.4M | $112.6M | $42.0M | $56.7M | $25.0M | $55.1M | $55.7M | $40.5M | $16.5M | $9.7M | $0.00 | $0.00 |
| Change In Fair Value Of Notes Payable | -$27.0K | -$304.0K | -$113.0K | $116.0K | $578.0K | -$748.0K | -$124.0K | $61.0K | -$59.0K | $110.0K | $56.7K | -$210.7K | $2.4M | $815.7K | $0.00 | ||
| Other Assets Current | $57.6M | $15.7M | $9.5M | $2.4M | $2.9M | $1.1M | $611.0K | $439.0K | $437.0K | $216.4K | $308.3K | $174.0K | $47.8K | $29.1K | $87.2K | ||
| Liabilities Current | $153.8M | $90.7M | $53.7M | $53.2M | $65.4M | $87.6M | $84.4M | $38.9M | $28.0M | $16.9M | $10.5M | $5.1M | $6.3M | $2.2M | $1.6M | ||
| Liabilities And Stockholders Equity | $1.06B | $577.7M | $329.6M | $193.6M | $379.6M | $625.6M | $163.0M | $83.6M | $97.4M | $54.8M | $113.5M | $86.7M | $48.1M | $22.1M | $14.5M | ||
| Deferred Compensation Liability Current | $21.9M | $15.2M | $12.2M | $8.4M | $10.2M | $8.5M | $3.8M | $2.3M | $1.8M | $1.4M | $818.5K | $702.0K | $532.5K | $145.0K | $0.00 | ||
| Property Plant And Equipment Net | $307.0K | $600.0K | $481.0K | $282.0K | $251.0K | $248.0K | $328.1K | $47.1K | $20.4K | $5.7K | $1.2K | $0.00 | |||||
| Goodwill | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | |||||
| Accounts Payable And Accrued Liabilities Current | $107.5M | $58.3M | $38.5M | $42.0M | $51.3M | $37.0M | $30.0M | $36.4M | $25.9M | $15.3M | $9.3M | $4.0M | $4.8M | ||||
| Short Term Investments | $62.8M | $131.1M | $124.6M | $59.4M | $15.9M | $52.0M | $27.8M | $26.9M | $28.0M | $19.9M | $22.2M | $23.1M | $0.00 | ||||
| Retained Earnings Accumulated Deficit | -$1.08B | -$1.53B | -$1.55B | -$1.53B | -$1.33B | -$980.6M | -$701.2M | -$528.3M | -$354.9M | -$236.4M | -$158.1M | -$95.2M | -$39.4M | ||||
| Treasury Stock Value | $100.2M | $9.0M | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.3K | $234.3K | $234.3K | $84.5K | $0.00 | |||||
| Cash And Cash Equivalents Period Increase Decrease | -$14.1M | $31.7M | -$30.0M | -$652.5K | $15.2M | $24.0M | $6.7M | $9.7M | |||||||||
| Treasury Stock Shares | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 13.5K | 0.00 | |||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $413.00 | ||||||||
| Change In Fair Value Of Non Current Note Payable | $1.0M | $720.0K | $3.3M | $1.7M | $0.00 | ||||||||||||
| Leasehold Interest | $1.6M | $1.8M | $2.1M | $2.1M | $2.3M | $2.4M | $2.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 | Q4 2004 | Q4 2003 | Q4 2002 | Q4 2001 | Q3 2001 | Q4 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $607.2M | $276.4M | $237.3M | $192.2M | $177.6M | $160.1M | $164.8M | $40.5M | $27.4M | $58.6M | $100.5M | $129.0M | $170.4M | $237.2M | $311.5M | $383.1M | $445.3M | $170.7M | $194.2M | -$1.4M | -$25.8M | $13.2M | $19.3M | $71.7M | $101.4M | $85.2M | $79.5M | $78.0M | $101.0M | $56.8M | $78.7M | $89.4M | $116.3M | $112.9M | $106.2M | $67.1M | $52.1M | $54.4M | $44.6M | $10.3M | $9.4M | $11.7M | -$294.6K | -$5.4M | -$6.8M | -$4.4M | -$891.1K | $1.5M | $9.5M | $4.2M | $6.8M | $637.9K | -$56.8K | $0.00 | |||||||||
| Cash And Cash Equivalents At Carrying Value | $74.1M | $129.1M | $132.1M | $195.8M | $82.9M | $75.5M | $150.9M | $97.0M | $61.5M | $109.9M | $147.1M | $185.7M | $326.5M | $401.7M | $471.5M | $254.2M | $260.5M | $52.1M | $44.7M | $57.2M | $64.3M | $70.7M | $105.7M | $82.9M | $91.8M | $77.6M | $95.6M | $29.2M | $28.6M | $36.5M | $65.5M | $60.3M | $86.0M | $53.2M | $37.1M | $49.6M | $50.2M | $13.4M | $15.2M | $17.4M | $20.4M | $20.9M | $0.00 | $0.00 | $0.00 | $0.00 | $1.1M | $0.00 | |||||||||||||||
| Change In Fair Value Of Notes Payable | -$213.0K | $35.0K | -$59.0K | $178.0K | $58.0K | $20.0K | -$66.0K | -$96.0K | -$106.0K | $58.6K | $3.0K | -$51.0K | $54.8K | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets Current | $55.8M | $25.4M | $20.4M | $32.6M | $7.0M | $8.1M | $12.1M | $11.1M | $4.5M | $3.0M | $3.1M | $4.0M | $2.5M | $3.0M | $4.8M | $641.0K | $1.5M | $1.9M | $864.0K | $987.0K | $1.5M | $526.0K | $816.0K | $978.0K | $796.3K | $927.7K | $1.1M | $500.6K | $649.7K | $730.5K | $457.9K | $548.8K | $701.9K | $258.7K | $197.9K | $359.9K | $118.4K | $136.7K | $64.7K | $79.0K | $100.8K | $141.6K | |||||||||||||||||||||
| Liabilities Current | $156.8M | $171.9M | $160.2M | $125.1M | $108.7M | $99.7M | $57.7M | $72.7M | $63.1M | $36.4M | $43.3M | $54.7M | $87.7M | $87.6M | $92.5M | $77.7M | $67.5M | $63.1M | $80.2M | $56.0M | $60.9M | $40.2M | $36.9M | $33.3M | $19.8M | $20.8M | $19.7M | $16.9M | $14.1M | $8.9M | $9.7M | $9.2M | $9.6M | $8.9M | $2.6M | $2.0M | $5.7M | $3.5M | $3.0M | $1.2M | $1.5M | $3.3M | |||||||||||||||||||||
| Liabilities And Stockholders Equity | $1.03B | $702.6M | $656.7M | $586.0M | $401.2M | $373.3M | $331.1M | $220.9M | $197.4M | $217.9M | $251.7M | $303.0M | $409.7M | $481.4M | $548.7M | $273.9M | $294.6M | $101.8M | $93.3M | $106.6M | $117.5M | $114.4M | $140.7M | $121.0M | $101.8M | $101.2M | $123.3M | $75.7M | $94.8M | $100.1M | $127.4M | $123.6M | $117.3M | $77.5M | $56.3M | $58.2M | $54.3M | $17.9M | $25.2M | $27.1M | $18.1M | $18.6M | |||||||||||||||||||||
| Deferred Compensation Liability Current | $15.0M | $10.6M | $5.1M | $10.1M | $6.4M | $3.6M | $8.3M | $6.6M | $3.2M | $4.3M | $2.9M | $1.6M | $12.9M | $8.5M | $3.5M | $5.1M | $3.4M | $1.4M | $3.0M | $1.7M | $854.0K | $2.1M | $1.2M | $456.0K | $1.3M | $896.8K | $483.6K | $1.1M | $796.4K | $449.1K | $768.8K | $506.0K | $248.0K | $599.1K | $395.5K | $197.3K | $350.0K | $232.8K | |||||||||||||||||||||||||
| Property Plant And Equipment Net | $66.0K | $95.0K | $133.0K | $206.0K | $237.0K | $376.0K | $447.0K | $526.0K | $600.0K | $597.0K | $488.0K | $378.0K | $331.0K | $320.0K | $275.0K | $237.0K | $241.0K | $268.0K | $265.0K | $252.0K | $268.4K | $289.3K | $307.7K | $327.7K | $333.9K | $323.0K | $69.2K | $34.8K | $24.8K | $7.8K | $7.3K | $8.2K | $3.8K | $2.5K | $1.3K | $1.6K | $3.0K | ||||||||||||||||||||||||||
| Goodwill | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.0K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $799.4K | $629.8K | $629.8K | |||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $112.3M | $134.0M | $133.9M | $101.4M | $93.5M | $87.3M | $39.7M | $62.9M | $57.1M | $29.7M | $37.2M | $49.7M | $44.7M | $40.2M | $42.8M | $34.7M | $29.7M | $30.9M | $31.8M | $31.5M | $40.2M | $37.9M | $35.4M | $32.5M | $18.2M | $19.6M | $18.9M | $15.6M | $13.1M | $8.1M | $8.6M | $8.3M | $8.9M | $8.0M | $1.9M | $1.6M | |||||||||||||||||||||||||||
| Short Term Investments | $57.5M | $122.7M | $144.1M | $145.2M | $134.3M | $134.3M | $78.3M | $47.9M | $78.2M | $66.1M | $48.6M | $47.5M | $30.3M | $41.8M | $52.3M | $15.1M | $26.3M | $27.8M | $27.7M | $28.1M | $27.0M | $20.6M | $26.2M | $0.00 | $8.8M | $13.8M | $31.4M | $25.7M | $22.2M | $28.7M | $31.8M | $19.1M | $14.0M | $8.0M | $3.9M | ||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.11B | -$1.50B | -$1.52B | -$1.55B | -$1.56B | -$1.53B | -$1.50B | -$1.61B | -$1.57B | -$1.47B | -$1.44B | -$1.40B | -$1.24B | -$1.15B | -$1.07B | -$892.4M | -$805.2M | -$752.3M | -$661.6M | $599.7M | -$563.5M | -$474.5M | -$440.5M | -$396.4M | -$324.0M | -$292.5M | -$264.1M | -$212.7M | -$187.9M | -$172.0M | -$140.5M | -$126.9M | -$109.8M | -$76.4M | -$58.9M | ||||||||||||||||||||||||||||
| Treasury Stock Value | $100.2M | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.0K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $234.3K | $84.5K | $84.5K | ||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $22.4M | $26.2M | $70.6M | -$18.6M | $30.3M | $9.1M | -$1.3M | $11.2M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury Stock Shares | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 41.3K | 13.5K | 13.5K | |||||||||||||||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.1K | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||
| Change In Fair Value Of Non Current Note Payable | $185.0K | $252.5K | $301.0K | $360.2K | $223.4K | $240.6K | $210.9K | $191.1K | $175.3K | $319.4K | $283.1K | $270.4K | $227.7K | $482.6K | -$205.3K | $0.00 | |||||||||||||||||||||||||||||||||||||||||||||||
| Leasehold Interest | $1.4M | $1.4M | $1.5M | $1.5M | $1.6M | $1.7M | $1.7M | $1.8M | $1.9M | $1.9M | $2.0M | $2.1M | $2.2M | $2.2M | $2.2M | $2.2M | $2.3M | $2.4M | $2.4M | $2.5M | $2.5M | $2.5M | $2.5M | $2.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $64.7M | $42.5M | $37.9M | $44.7M | $61.3M | $80.3M | $11.3M | $12.9M | $15.9M | $7.5M | $15.7M | $21.1M | $5.2M | $3.4M | $86.5K |
| Financing Cash Flow * | -$89.7M | $128.5M | $72.7M | -$391.0K | $41.4M | $679.8M | $204.2M | $113.6M | $133.7M | $5.0M | $68.7M | $68.6M | $39.7M | $11.9M | $9.8M |
| Investing Cash Flow * | $13.8M | -$1.0M | -$50.7M | -$20.0M | -$332.0K | -$24.5M | -$718.0K | $1.2M | -$8.2M | $26.5M | -$24.7M | -$18.4M | -$4.9M | -$1.4K | $10.4K |
| Operating Cash Flow * | -$24.8M | -$40.5M | -$31.4M | -$176.2M | -$295.6M | -$214.5M | -$132.8M | -$128.9M | -$93.8M | -$61.6M | -$44.7M | -$35.1M | -$10.7M | -$5.2M | -$86.6K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $68.2M | $46.3M | $40.8M | $44.7M | $61.3M | $80.3M | $11.3M | $12.9M | $15.9M | $7.5M | $15.7M | $21.1M | $5.2M | $188.5K | $86.5K |
| Payments To Acquire Property Plant And Equipment | $214.0K | $45.0K | $0.00 | $14.0K | $401.0K | $357.0K | $131.0K | $90.0K | $2.0K | $344.0K | $42.2K | $18.6K | $5.7K | $1.4K | $0.00 |
| Increase Decrease In Other Current Assets | $42.4M | $6.3M | $2.8M | -$8.2M | $8.5M | -$2.3M | -$1.4M | $1.6M | $2.7M | -$3.6M | $3.1M | $4.6M | -$229.3K | $1.9M | -$3.6K |
| Increase Decrease In Deferred Revenue | $6.4M | $17.5M | $5.7M | -$152.0K | -$152.0K | -$152.0K | -$152.0K | -$152.0K | -$152.0K | -$152.0K | -$152.4K | -$152.4K | -$152.4K | $2.0M | $0.00 |
| Proceeds From Warrant Exercises | $584.0K | $216.0K | $147.0K | $0.00 | $0.00 | $2.1M | $618.0K | $1.1M | $3.6M | $2.3M | $0.00 | ||||
| Proceeds From Maturities | $87.3M | $55.6M | $43.3M | $29.3M | $32.5M | $19.8M | $29.5M | $24.4M | $0.00 | $0.00 | |||||
| Payments To Acquire Held To Maturity Securities Short Term | $107.3M | $55.5M | $67.4M | $29.8M | $31.2M | $28.0M | $15.2M | $49.0M | $18.3M | $4.9M | |||||
| Increase Decrease In Interest Payable Net | -$43.0K | $1.5M | $0.00 | $0.00 | $0.00 | $0.00 | -$94.6K | $66.5K | $61.6K | $7.1K | |||||
| Increase Decrease In Accrued Interest Receivable Net | $6.0K | $11.0K | -$14.0K | $25.0K | -$102.0K | $100.5K | $58.3K | $27.2K | $0.00 | ||||||
| Payments Of Financing Costs | $0.00 | $889.0K | $125.0K | $0.00 | $1.0M | $0.00 | $795.0K | $0.00 | $0.00 | $13.0K | $104.2K | $52.0K | $85.1K | ||
| Increase Decrease In Other Current Liabilities | -$2.4M | $4.0M | $2.7M | $2.3M | -$16.1M | -$31.5M | $30.3M | $18.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $15.0M | $9.3M | $6.8M | $7.0M | -$1.0M | $2.1M | $14.0M | $16.3M | $16.6M | $28.3M | $7.4M | $11.1M | $2.1M | $1.8M | $1.9M | $7.3M | $6.0M | $2.8M | $1.6M | $1.7M | $1.2M | $6.2M | $5.4M | $4.1M | $7.7M | $4.2M | $996.8K | $1.4M | $1.9M | $818.1K | $188.5K | ||||||||
| Financing Cash Flow * | -$6.1M | $10.0K | $25.2M | -$850.0K | -$55.0K | $81.0K | $56.9M | $52.4M | $86.9M | $14.2K | $35.3M | $17.4M | $936.9K | $12.0M | |||||||||||||||||||||||||
| Investing Cash Flow * | -$12.9M | -$9.3M | -$6.2M | -$43.7M | -$514.0K | $1.5M | -$1.1M | $1.8M | $6.0M | -$1.9M | $3.8M | -$3.2K | $0.00 | $0.00 | |||||||||||||||||||||||||
| Operating Cash Flow * | -$28.7M | -$8.2M | -$59.9M | -$68.7M | -$81.4M | -$62.1M | -$33.4M | -$28.0M | -$22.3M | -$16.7M | -$8.9M | -$8.3M | -$2.2M | -$861.6K | |||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $18.1M | $17.4M | $16.0M | $12.7M | $10.4M | $10.3M | $10.0M | $13.6M | $7.1M | $7.0M | -$975.0K | $2.1M | $14.0M | $16.3M | $16.6M | $28.3M | $7.4M | $11.1M | $2.1M | $1.8M | $1.9M | -$173.0K | $4.3M | $7.3M | $6.0M | $1.7M | $5.4M | $4.2M | |||||||||||
| Payments To Acquire Property Plant And Equipment | $25.0K | $0.00 | $7.0K | $67.0K | $68.0K | $14.0K | $24.0K | $0.00 | $282.3K | $6.9K | $3.2K | $0.00 | |||||||||||||||||||||||||||
| Increase Decrease In Other Current Assets | $4.6M | -$1.5M | $2.6M | -$6.8M | $4.1M | $1.0M | $2.5M | -$691.0K | $3.6M | $2.3M | $4.2M | $988.3K | $580.7K | ||||||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | $140.0K | $602.0K | -$38.0K | -$38.0K | -$38.0K | -$38.0K | -$38.0K | -$38.0K | -$38.0K | -$38.1K | -$38.1K | -$38.1K | -$38.1K | ||||||||||||||||||||||||||
| Proceeds From Warrant Exercises | $363.0K | $125.0K | $128.0K | $81.0K | $0.00 | $2.1M | $22.2K | $408.3K | $901.5K | $936.9K | |||||||||||||||||||||||||||||
| Proceeds From Maturities | $16.0M | $13.2M | $17.0M | $9.0M | $7.1M | $6.0M | $6.0M | $9.0M | $3.9M | ||||||||||||||||||||||||||||||
| Payments To Acquire Held To Maturity Securities Short Term | $22.2M | $56.9M | $17.4M | $7.5M | $8.2M | $4.2M | $0.00 | $10.6M | $0.00 | ||||||||||||||||||||||||||||||
| Increase Decrease In Interest Payable Net | -$832.0K | $549.0K | $0.00 | $0.00 | -$94.6K | $15.9K | $14.9K | ||||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Interest Receivable Net | -$40.0K | -$14.0K | -$30.0K | -$61.0K | -$21.9K | $4.2K | -$16.0K | $0.00 | |||||||||||||||||||||||||||||||
| Payments Of Financing Costs | $125.0K | $538.0K | $0.00 | $8.0K | $19.4K | $0.00 | |||||||||||||||||||||||||||||||||
| Increase Decrease In Other Current Liabilities | -$1.9M | $3.0M | $619.0K | $539.0K | -$3.7M | -$19.7M | -$559.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $2.77 | $0.15 | $0.09 | -$1.65 | -$2.63 | -$2.42 | -$1.96 | -$2.30 | -$1.91 | -$1.60 | -$1.38 | -$1.64 | -$0.81 | -$1.38 | -$0.44 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 132.2M | 115.3M | 88.4M | 75.5M | 62.1M | 49.0M | 45.6M | 34.1M | 25.4M | 13.1M | 1.9M | ||||
| Common Stock Shares Authorized | 190.0M | 190.0M | 175.0M | 175.0M | 175.0M | 175.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 500.0M | 500.0M | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 158.8M | 156.2M | 151.5M | 146.4M | 143.3M | 140.6M | 109.4M | 83.9M | 73.2M | 56.8M | 54.1M | 45.0M | 34.3M | 25.8M | 5.1M |
| Common Stock Shares Outstanding | 155.3M | 155.8M | 151.4M | 146.4M | 143.3M | 140.6M | 109.4M | 83.9M | 73.1M | 56.8M | 54.1M | 44.9M | 34.3M | 25.8M | 5.1M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 413.4K | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 413.4K | ||||||
| Earnings Per Share Basic | $3.10 | $0.16 | $0.09 | $-1.65 | $-2.63 | $-2.42 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q4 2010 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $2.43 | $0.17 | $0.03 | $0.02 | $0.04 | -$0.07 | $0.73 | -$0.34 | -$0.28 | -$0.26 | -$0.30 | -$0.51 | -$0.65 | -$0.59 | -$0.69 | -$0.73 | -$0.47 | -$0.48 | -$0.44 | -$0.69 | -$0.42 | -$0.43 | -$0.68 | -$0.43 | -$0.59 | -$0.59 | -$0.46 | -$0.48 | -$0.45 | -$0.52 | -$0.48 | -$0.50 | -$0.33 | -$0.28 | -$0.37 | -$0.28 | -$0.38 | -$0.35 | -$0.48 | -$0.51 | -$0.36 | -$0.25 | -$0.16 | -$0.29 | -$0.17 | -$0.16 | -$0.16 | -$2.03 | -$0.01 | $0.02 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 132.4M | 132.1M | 131.9M | 119.2M | 112.4M | 105.5M | 89.7M | 86.8M | 81.2M | 78.2M | 74.3M | 70.6M | 65.1M | 63.3M | 53.2M | 49.2M | 48.8M | 48.9M | 47.9M | 45.3M | 41.1M | 34.2M | 33.0M | 30.1M | 27.7M | 22.5M | 22.0M | 15.8M | 11.8M | 2.6M | ||||||||||||||||||||||
| Common Stock Shares Authorized | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Issued | 158.8M | 158.8M | 158.7M | 155.9M | 154.9M | 154.6M | 151.5M | 151.0M | 149.4M | 145.4M | 145.2M | 144.6M | 143.0M | 142.9M | 141.5M | 129.0M | 126.7M | 110.2M | 96.7M | 93.4M | 88.6M | 83.0M | 82.5M | 77.1M | 70.7M | 68.1M | 66.8M | 54.8M | 54.5M | 54.1M | 52.6M | 51.7M | 47.5M | 41.5M | 38.2M | 37.5M | 33.4M | 26.7M | 20.1M | 5.1M | 7.4M | 2.4M | ||||||||||
| Common Stock Shares Outstanding | 155.2M | 158.0M | 158.2M | 155.8M | 154.8M | 154.6M | 151.4M | 150.9M | 149.4M | 145.4M | 145.2M | 144.5M | 142.9M | 142.8M | 141.5M | 128.9M | 126.6M | 110.2M | 96.6M | 93.4M | 88.5M | 82.9M | 82.5M | 77.1M | 70.7M | 68.1M | 66.8M | 54.7M | 54.5M | 54.1M | 52.5M | 51.7M | 47.4M | 41.4M | 38.1M | 37.5M | 33.4M | 26.7M | 20.1M | 5.1M | 7.4M | 2.4M | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.5M | 1.5M | ||||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.1M | 0.00 | 0.00 | |||||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.1M | 0.00 | 0.00 | |||||||||||||||||||||||||||||
| Earnings Per Share Basic | $2.69 | $0.19 | $0.03 | $0.03 | $0.05 | $-0.07 | $0.80 | $-0.34 | $-0.28 | $-0.26 | $-0.30 | $-0.51 | $-0.65 | $-0.59 | $-0.69 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Income | $4.7M | $2.3M | $542.0K | $1.5M | $1.8M | $1.1M | $393.0K | $56.7K | -$115.2K | $108.9K | $272.2K | $0.00 | |||
| Stock Issued During Period Value Stock Options Exercised | $1.5M | $914.0K | $1.5M | $584.0K | $216.0K | $146.0K | $202.4K | ||||||||
| Interest Income Other | $857.0K | $295.0K | $323.0K | $174.7K | $55.0K | $30.8K | |||||||||
| Amortization Of Financing Costs | $1.2M | $2.0M | $2.4M | $1.8M | $1.1M | $925.0K | $772.0K | $0.00 | $0.00 | ||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.2K | ||||
| Net Proceeds From Shares New Issues Overallotments | 2.2M | 679.7M | 175.0M | 113.6M | 131.5M | 4.4M | 67.8M | 65.6M | 37.6M | ||||||
| Investment Income Amortization Of Premium | $517.0K | -$119.0K | $61.0K | $459.0K | $536.1K | $193.6K | $975.00 | $0.00 | |||||||
| Stock Issued During Period Value New Issues | $462.2M | $77.5M | $113.6M | $53.6M | $4.4M | $16.8M | $37.6M | $12.2M | $9.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Income | $691.0K | $604.0K | $793.0K | $1.4M | $523.0K | $529.0K | $618.0K | $472.0K | $169.0K | $189.0K | $330.0K | $468.0K | $408.0K | $307.0K | $598.0K | $426.0K | -$96.0K | -$30.0K | $22.0K | -$106.0K | $6.5K | $31.8K | $58.6K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $95.4K | $0.00 | $0.00 | $0.00 | $0.00 | $272.2K | $0.00 | ||||||||
| Stock Issued During Period Value Stock Options Exercised | $432.0K | $21.0K | $199.0K | $135.0K | $10.0K | $420.0K | $751.0K | $363.0K | $275.0K | $135.0K | $125.0K | $50.0K | $38.0K | $128.0K | $38.0K | $16.0K | $80.0K | ||||||||||||||||||||||||||
| Interest Income Other | $1.1M | $149.0K | $258.0K | $223.0K | $144.0K | $79.0K | $50.0K | $45.0K | $88.0K | $92.6K | $84.9K | $56.0K | $31.6K | $22.1K | $12.1K | $12.7K | $13.5K | $12.4K | $1.2K | $1.5K | |||||||||||||||||||||||
| Amortization Of Financing Costs | $304.0K | $639.0K | $461.0K | $461.0K | $300.0K | $231.0K | $200.0K | $231.0K | $200.0K | $200.0K | $77.0K | $0.00 | $0.00 | $427.8K | |||||||||||||||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Net Proceeds From Shares New Issues Overallotments | 27.7M | 52.4M | 84.8M | 0.00 | 34.9M | 17.2M | |||||||||||||||||||||||||||||||||||||
| Investment Income Amortization Of Premium | $23.0K | $127.0K | -$75.0K | $2.0K | $31.0K | $128.3K | $80.6K | $15.3K | $0.00 | ||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $46.3M | -$1.0K | $165.0M | $11.0K | $27.5M | $750.0K | $16.8M | $12.2M |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.